The Future of Gene Therapy: Insights from Biotech Leader Jose F Gomez
)
What does the future hold for gene therapy? Ben Brickell interviewed Jose F. Gomez and asked him about his career, his experience transitioning from Big Pharma to smaller biotech, and the current challenges facing the gene therapy industry.
Jose F. Gomez is a biotech global commercial leader with deep expertise in commercialization and market access of gene therapies (in vivo and ex vivo), orphan drugs and specialty pharmaceutical products. Jose has extensive experience in strategic marketing, patient access & value, new product planning, business development, and health policy. He successfully built and led global market access, reimbursement & value functions at several leading biopharma companies, including Avrobio, AveXis (now Novartis Gene Therapies), Shire, and Abbott.
Ben Brickell is the Director of the Venari Partners' Life Sciences & Healthcare practice. He works exclusively with emerging Biotech, MedTech and HealthTech companies across Europe and North America, and brings deep functional expertise from R&D through to Commercial. He can provide specialist support at every stage of his clients’ growth journey.
Cristian joined Venari Partners in 2019 and specialises in executive search across digital health and healthtech. He works closely with emerging and high-growth businesses across the US and Europe, helping them build leadership teams to support their growth and commercial ambitions. His sector expertise spans SaaS, digital therapeutics, AI, virtual care, real-world evidence (RWE) and healthcare IT, with a focus on senior appointments across strategy, business development, operations and commercial functions. With extensive experience supporting healthtech companies through key stages of growth, Cristian advises on C-suite, VP and Director-level appointments, board recruitment and succession planning. He also provides specialist support with US go-to-market expansion for European businesses, alongside interim solutions, market mapping, compensation benchmarking and leadership and organisational assessments. Combining deep sector knowledge with an understanding of the challenges facing growing healthtech businesses, Cristian brings a considered approach to identifying leadership talent and supporting organisations through critical stages of development.
View Full Profile)
)
)
)
)
